Global X Data Center & Digital Infra ETF vs Heron Therapeutics Inc — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.69 (market cap $2.04B), while Heron Therapeutics Inc trades at $0.39 (market cap $68.01M). The key difference: Global X Data Center & Digital Infra ETF is far larger — about 30× Heron Therapeutics Inc's market cap, and Global X Data Center & Digital Infra ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and Heron Therapeutics Inc for 35 Days on average.
| DTCR | HRTX | |
|---|---|---|
Market Cap | $2.04B | $68.01M |
Volume | 899,532 | 1,891,941 |
Sector | Sector/Thematic | Health |
52-Week High | $32.46 | $1.49 |
52-Week Low | $19.73 | $0.27 |
Typical Hold Time | 15 Days | 35 Days |
Enterprise Value | — | $174.75M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.
Read more on DTCR →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →